{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:01:28Z","timestamp":1760853688331},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijid.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T18:17:43Z","timestamp":1379096263000},"page":"e1154-e1159","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early changes in hepatic function among HIV\u2013tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"C.","family":"Padmapriyadarsini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.K.","family":"Bhavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanth","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ponnuraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hannah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.08.006_bib0005","unstructured":"World Health Organization. Global tuberculosis control 2010. Geneva: WHO; 2010. Available at: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241564069_eng.pdf (accessed on May 9, 2011)."},{"key":"10.1016\/j.ijid.2013.08.006_bib0010","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendation for a public health approach. Geneva: WHO: 2010. Available at: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf (accessed on September 9, 2010)."},{"key":"10.1016\/j.ijid.2013.08.006_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/651686","article-title":"Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis","volume":"50","author":"Khan","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2013.08.006_bib0025","unstructured":"World Health Organization. Treatment of tuberculosis. 4th ed. Geneva: WHO; 2010. Available at: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547833_eng.pdf (accessed September 9, 2010)."},{"key":"10.1016\/j.ijid.2013.08.006_bib0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/01.aids.0000183630.27665.30","article-title":"Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin","volume":"19","author":"Manosuthi","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.08.006_bib0035","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jac\/dkl399","article-title":"Administration of efavirenz (600mg\/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV","volume":"58","author":"Friedland","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2013.08.006_bib0040","first-page":"360","article-title":"Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB\u2013HIV coinfection in Botswana","volume":"13","author":"Shipton","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2013.08.006_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-3879(86)90003-6","article-title":"Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide","volume":"67","author":"Parthasarathy","year":"1986","journal-title":"Tubercle"},{"key":"10.1016\/j.ijid.2013.08.006_bib0050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/cid\/ciq195","article-title":"Dyslipidemia among HIV infected patients with tuberculosis taking once-daily nonnucleoside reverse transcriptase inhibitor based antiretroviral therapy in India","volume":"52","author":"Padmapriyadarsini","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2013.08.006_bib0055","unstructured":"DAIDS Table for grading the severity of adult and pediatric adverse events. Bethesda, MD: Division of AIDS, National Institute of Allergy and Infectious Diseases; 2004. Available at: http:\/\/www.niaid.nih.gov\/LabsAndResources\/resources\/DAIDSClinRsrch\/Documents\/daidsaegradingtable.pdf (accessed on 23rd July 2013)."},{"key":"10.1016\/j.ijid.2013.08.006_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/apc.2008.0020","article-title":"Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda","volume":"22","author":"Weidle","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ijid.2013.08.006_bib0065","first-page":"197","article-title":"Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi","volume":"14","author":"Moses","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2013.08.006_bib0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00002030-200303070-00024","article-title":"Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis","volume":"17","author":"Olivia","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.08.006_bib0075","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/cid\/cir447","article-title":"Efficacy and safety of once-daily nevirapine or efavirenz based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial","volume":"53","author":"Swaminathan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2013.08.006_bib0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1310\/EWWC-YLJ6-8LHE-054A","article-title":"Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine","volume":"6","author":"Manfredi","year":"2005","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.ijid.2013.08.006_bib0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1545109707304494","article-title":"Adverse events in HIV-infected persons receiving antiretroviral drug regimens in a large urban slum in Nairobi, Kenya, 2003\u20132005","volume":"6","author":"Kim","year":"2007","journal-title":"J Int Assoc Physician AIDS Care (Chic.)"},{"key":"10.1016\/j.ijid.2013.08.006_bib0090","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.qai.0000135956.96166.f0","article-title":"Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral na\u00efve patients in India who are coinfected with tuberculosis and HIV-1","volume":"37","author":"Patel","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.08.006_bib0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1468-1293.2008.00563.x","article-title":"Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin","volume":"9","author":"Manosuthi","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2013.08.006_bib0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S1413-86702004000300004","article-title":"Efficacy and safety of efavirenz in HIV patients on rifampin for tuberculosis","volume":"8","author":"Pedral-Sampaio","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2013.08.006_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/QAI.0b013e31824e9ef2","article-title":"The effect of HIV infection, immunodeficiency and antiretroviral therapy on the risk of hepatic dysfunction","volume":"60","author":"Towner","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2013.08.006_bib0110","doi-asserted-by":"crossref","first-page":"s21","DOI":"10.1097\/00126334-200309011-00005","article-title":"A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients","volume":"34","author":"Stern","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.08.006_bib0115","first-page":"92","article-title":"Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function","volume":"52","author":"Padmapriyadarsini","year":"2006","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.ijid.2013.08.006_bib0120","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.3748\/wjg.v13.i37.5015","article-title":"Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India","volume":"13","author":"Saravanan","year":"2007","journal-title":"World J Gastroenterol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121300266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121300266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T03:53:19Z","timestamp":1539402799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121300266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S120197121300266X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.08.006","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early changes in hepatic function among HIV\u2013tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}